BACKGROUND: Treatment of pediatric arteriovenous malformations (AVMs) is always a challenge considering their hemorrhagic presentation, associated morbidity and mortality, and the potential long life span of these children. Spetzler-Martin grades I-III are the grey zones as far as the treatment options are concerned. With a generous multimodality approach, one can reduce the morbidity and mortality to a considerable extent. OBJECTIVE: To analyze the demographic and clinico-radiological profile of pediatric intracranial AVMs belonging to Spetzler-Martin grades I-III and their outcome following microsurgical excision. METHODS: Pediatric patients (≤18 years of age) from a period of January 2001-January 2011 were included in the study. Patients with associated aneurysms or tumors were excluded from the study. Post-operative DSA/CT angiography was done within 6 weeks after surgery. Outcome was analyzed in terms of neurological improvement according to Medical Research Council Grade (MRC), obliteration of the AVM in post-operative angiography and Modified Rankin score. Outcome based on Modified Rankin score was favorable with a score of 0-2 and unfavorable when the score was 3-6. RESULTS: A total of 36 patients with a mean follow-up of 12.75 months were identified. Thirty-one patients (86.1%) presented with hemorrhage while only 15 (41.6%) presented with seizures. There were 25 (69.4%) males and 11 (30.6%) females. Spetzler-Martin grade was grade I in six patients, grade II in 20 patients, and grade III in ten patients. All patients underwent surgical excision of the AVMs and post-operative angiography showed a 100% obliteration rate. There was a favorable outcome in 86.1% of the patients according to modified Rankin score. CONCLUSION: The aim of treating a pediatric AVM should be complete obliteration of the AVM considering the high risk of hemorrhage and the morbidity and mortality associated with hemorrhage. With careful planning and adopting a multimodality treatment, complete obliteration can definitely be achieved.
BACKGROUND: Treatment of pediatric arteriovenous malformations (AVMs) is always a challenge considering their hemorrhagic presentation, associated morbidity and mortality, and the potential long life span of these children. Spetzler-Martin grades I-III are the grey zones as far as the treatment options are concerned. With a generous multimodality approach, one can reduce the morbidity and mortality to a considerable extent. OBJECTIVE: To analyze the demographic and clinico-radiological profile of pediatric intracranial AVMs belonging to Spetzler-Martin grades I-III and their outcome following microsurgical excision. METHODS: Pediatric patients (≤18 years of age) from a period of January 2001-January 2011 were included in the study. Patients with associated aneurysms or tumors were excluded from the study. Post-operative DSA/CT angiography was done within 6 weeks after surgery. Outcome was analyzed in terms of neurological improvement according to Medical Research Council Grade (MRC), obliteration of the AVM in post-operative angiography and Modified Rankin score. Outcome based on Modified Rankin score was favorable with a score of 0-2 and unfavorable when the score was 3-6. RESULTS: A total of 36 patients with a mean follow-up of 12.75 months were identified. Thirty-one patients (86.1%) presented with hemorrhage while only 15 (41.6%) presented with seizures. There were 25 (69.4%) males and 11 (30.6%) females. Spetzler-Martin grade was grade I in six patients, grade II in 20 patients, and grade III in ten patients. All patients underwent surgical excision of the AVMs and post-operative angiography showed a 100% obliteration rate. There was a favorable outcome in 86.1% of the patients according to modified Rankin score. CONCLUSION: The aim of treating a pediatric AVM should be complete obliteration of the AVM considering the high risk of hemorrhage and the morbidity and mortality associated with hemorrhage. With careful planning and adopting a multimodality treatment, complete obliteration can definitely be achieved.
Authors: Antonio Nicolato; Francesco Lupidi; Marco F Sandri; Roberto Foroni; Piergiuseppe Zampieri; Carlo Mazza; Alberto Pasqualin; Alberto Beltramello; Massimo Gerosa Journal: Int J Radiat Oncol Biol Phys Date: 2005-12-09 Impact factor: 7.038
Authors: Antonio Nicolato; Roberto Foroni; Andrea Seghedoni; Valentina Martines; Francesco Lupidi; Piergiuseppe Zampieri; Marco F Sandri; Umberto Ricci; Carlo Mazza; Alberto Beltramello; Massimo Gerosa; Albino Bricolo Journal: Childs Nerv Syst Date: 2005-01-15 Impact factor: 1.475
Authors: Omar M Arnaout; Bradley A Gross; Christopher S Eddleman; Bernard R Bendok; Christopher C Getch; H Hunt Batjer Journal: Neurosurg Focus Date: 2009-05 Impact factor: 4.047
Authors: A V Khaw; J P Mohr; R R Sciacca; H C Schumacher; A Hartmann; J Pile-Spellman; H Mast; C Stapf Journal: Stroke Date: 2004-01-29 Impact factor: 7.914
Authors: Juha A Hernesniemi; Reza Dashti; Seppo Juvela; Kristjan Väärt; Mika Niemelä; Aki Laakso Journal: Neurosurgery Date: 2008-11 Impact factor: 4.654
Authors: L H de Castro-Afonso; G S Nakiri; R S Oliveira; M V Santos; A C Dos Santos; H R Machado; D G Abud Journal: Neuroradiology Date: 2016-02-24 Impact factor: 2.804
Authors: Lexa K Murphy; Bruce E Compas; Melissa C Gindville; Kristen L Reeslund; Lori C Jordan Journal: Dev Med Child Neurol Date: 2017-09-06 Impact factor: 5.449